Prolyl-4-hydroxylase domain (PHD) dioxygenases are oxygen sensors that regulate hypoxia-inducible factor 2 (HIF-2) and erythropoietin (EPO) production. Now, researchers have shown that renal EPO-producing cells (REPCs) are derived from FOXD1-expressing cells and consist of various subpopulations that are heterogeneous in their response to Phd2 inactivation, regulation of HIF-2 activity, and EPO production. Mouse genetic studies showed that PHD2 is the main regulator of REPC plasticity, which the researchers suggest could be of clinical relevance.